Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Clearside Biomedical, Inc. (CLSD)  
$1.29 0.05 (3.73%) as of 4:30 Mon 4/29


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 48,350,000
Market Cap: 62.37(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.68 - $2.02
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 12.2
Insider 6 Months    : 13.1
Insider 3/6 Months : 25.3
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Clearside Biomedical is a biopharmaceutical company focused on delivering therapies to the back of the eye through the suprachoroidal space (SCS). Co.'s SCS injection platform, utilizing its SCS Microinjector, enables non-surgical procedure for the targeted delivery of therapies to the macula, retina or choroid to preserve and improve vision in patients with sight-threatening eye diseases. Co. is utilizing its SCS injection platform by building a research and development pipeline targeting retinal diseases and by creating external collaborations with other companies. Co.'s product is XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use in therapy for macular edema.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 574,444 710,222 730,222 774,222
Total Buy Value $777,664 $877,513 $894,713 $948,879
Total People Bought 3 3 5 5
Total Buy Transactions 4 7 9 11
Total Shares Sold 0 30,900 30,900 80,830
Total Sell Value $0 $39,372 $39,372 $113,315
Total People Sold 0 2 2 3
Total Sell Transactions 0 2 2 6
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 194
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gibney Anthony S   –       •      –    2024-04-18 4 B $1.30 $121,277 D/D 93,290 100,000 0.01 2%     
   Gibney Anthony S   –       •      –    2024-04-17 4 B $1.25 $8,388 D/D 6,710 6,710 0.01 2%     
   Chong Ngai Hang Victor CHIEF MEDICAL OFFICER   •       –      –    2024-03-20 4 B $1.60 $48,000 D/D 30,000 30,000 0.01 -18%     
   Whitmore Bradford T 10% Owner   –       –       •   2024-02-07 4 B $1.35 $599,999 D/D 444,444 4,495,034 2.45 -3%     
   Lasezkay George M CEO   •       •      –    2024-01-19 4 S $1.27 $22,860 D/D (18,000) 466,577 -4%     
   Deignan Charles A. Chief Financial Officer   •       –      –    2024-01-19 4 S $1.28 $16,512 D/D (12,900) 384,662 -4%     
   Whitmore Bradford T 10% Owner   –       –       •   2023-11-01 4 B $0.74 $47,901 D/D 64,366 4,050,590 2.37 114%     
   Whitmore Bradford T 10% Owner   –       –       •   2023-10-31 4 B $0.73 $51,537 D/D 70,812 3,986,224 2.45 126%     
   Whitmore Bradford T 10% Owner   –       –       •   2023-10-30 4 B $0.69 $411 D/D 600 3,915,412 2.37 193%     
   Whitmore Bradford T 10% Owner   –       –       •   2023-10-27 3 IO $0.00 $0 I/I 0 2,350,152 138%     
   Whitmore Bradford T 10% Owner   –       –       •   2023-10-27 3 IO $0.00 $0 D/D 0 3,914,812 138%     
   Hutson Nancy J Director   –       •      –    2023-10-03 4 B $0.86 $8,600 D/D 10,000 93,000 2.39 63%     
   Thorp Clay Director   –       •      –    2023-09-25 4 B $0.86 $8,600 D/D 10,000 40,522 2.39 61%     
   Humphries William D. Director   –       •      –    2023-09-22 4 OE $0.40 $9,091 D/D 22,727 51,040     -
   Deignan Charles A. Chief Financial Officer   •       –      –    2023-09-13 4 OE $0.40 $13,636 D/D 34,090 397,562     -
   Ciulla Thomas Chief Medical Officer   •       –      –    2023-01-20 4 AS $1.47 $20,139 D/D (13,700) 291,890 -28%     
   Deignan Charles A. Chief Financial Officer   •       –      –    2023-01-19 4 AS $1.50 $21,045 D/D (14,030) 363,472 -28%     
   Lasezkay George M CEO   •       •      –    2023-01-19 4 AS $1.46 $29,244 D/D (20,030) 484,577 -28%     
   Ciulla Thomas Chief Medical Officer   •       –      –    2023-01-10 4 AS $1.62 $3,515 D/D (2,170) 305,590 -39%     
   Thorp Clay Director   –       •      –    2022-12-21 4 B $1.02 $14,266 D/D 14,000 30,522 2.39 -0%     
   Deignan Charles A. Chief Financial Officer   •       –      –    2022-12-20 4 OE $0.40 $9,454 D/D 23,636 377,502     -
   Thorp Clay Director   –       •      –    2022-12-15 4 A $0.00 $0 D/D 8,522 16,522     -
   Thorp Clay Director   –       •      –    2022-12-15 4 D $0.00 $0 I/I (1,406,507) 3,545,040     -
   Hutson Nancy J Director   –       •      –    2022-11-17 4 B $1.33 $39,900 D/D 30,000 83,000 2.39 -23%     
   Yerxa Benjamin R Director   –       •      –    2022-03-02 3 IO $0.00 $0 D/D 0 10,144 15%     
  194 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us